Robbins LLP Urges UNCY Stockholders with Significant Losses to Contact the Firm for Information About the Unicycive Therapeutics, Inc. Class Action
SAN DIEGO, Sept. 30, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Unicycive Therapeutics, Inc. (NASDAQ: UNCY) securities between December 29, 2025 and June...